Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,68 USD | +2,29% | +3,08% | +77,48% |
17/04 | NUVATION BIO INC. : RBC Capital Markets geeft koopadvies | ZM |
10/04 | Nuvation Bio rondt overname van AnHeart Therapeutics af | MT |
Vakgebied
Aantal werknemers: 51
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David Hung
FOU | Founder | 66 | 20-03-18 |
Moses Makunje
DFI | Director of Finance/CFO | 46 | 01-07-20 |
Dong Fang Liu
CTO | Chief Tech/Sci/R&D Officer | 54 | 18-07-22 |
Gary Hattersley
CTO | Chief Tech/Sci/R&D Officer | 57 | 01-06-19 |
David Hanley
PRN | Corporate Officer/Principal | 54 | 01-06-21 |
Stacy Markel
HRO | Human Resources Officer | 59 | 01-10-19 |
Kerry Wentworth
LAW | General Counsel | 51 | 18-07-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Hung
FOU | Founder | 66 | 20-03-18 |
Kim Blickenstaff
BRD | Director/Board Member | 71 | 01-08-19 |
Kathryn Falberg
BRD | Director/Board Member | 63 | 01-10-20 |
Daniel Welch
CHM | Chairman | 66 | 01-07-20 |
Robert D. Mashal
BRD | Director/Board Member | - | 08/01 |
Tony Vernon
BRD | Director/Board Member | 68 | 01-06-19 |
Director/Board Member | 56 | 01-07-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 1 000 000 | 0 | 0 | 75,17 % |
Aandeel B | 1 | 245 692 474 | 185 427 238 ( 75,47 %) | 0 | |
Aandeel C | 0 | 851 202 | 0 | 0 |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+77,48% | 704 mln. | |
+1,51% | 42,75 mld. | |
+49,22% | 41,61 mld. | |
+8,57% | 41,34 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |
- Beurs
- Aandelen
- Koers NUVB
- Onderneming Nuvation Bio Inc.